Prospects of nanotechnology and natural products for cancer and immunotherapy

• Jan Filipe Andrade Santos,
• Marcela Bernardes Brasileiro,
• Pamela Danielle Cavalcante Barreto,
• Ligiane Aranha Rocha and
• José Adão Carvalho Nascimento Júnior

Beilstein J. Nanotechnol. 2025, 16, 1644–1667, doi:10.3762/bjnano.16.116

• ]. Additionally, the use of biomimetic nanoparticles, including exosome-based delivery systems and cell membrane-coated nanoparticles, has shown promise in improving targeting efficiency and immune evasion [18][19]. Despite these advances, significant challenges remain, including nanoparticle stability in

Better together: biomimetic nanomedicines for high performance tumor therapy

• Imran Shair Mohammad,
• Gizem Kursunluoglu,
• Anup Kumar Patel,
• Hafiz Muhammad Ishaq,
• Cansu Umran Tunc,
• Dilek Kanarya,
• Mubashar Rehman,
• Omer Aydin and
• Yin Lifang

Beilstein J. Nanotechnol. 2025, 16, 1246–1276, doi:10.3762/bjnano.16.92

• 38040, Turkey Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing 211198, PR China 10.3762/bjnano.16.92 Abstract The emergence of nanotechnology offers a promising avenue for enhancing cancer treatment outcomes. In this context, biomimetic nanoparticles have

• inherent traits endow biomimetic nanoparticles with a suite of intelligent features, including biocompatibility, low immunogenicity, reduced toxicity, immune evasion, prolonged circulation, homotypic binding, enhanced tumor targeting, and the capability of precise delivery. By integrating biologically

• applications. This discussion delves into the challenges and opportunities presented by biomimetic nanoparticles and offers a comprehensive exploration of their fundamentals and recent breakthroughs, with an eye towards clinical translation. By bridging the gap between scientific innovation and clinical

Biomimetic nanocarriers: integrating natural functions for advanced therapeutic applications

• Hugo Felix Perini,
• Beatriz Sodré Matos,
• Carlo José Freire de Oliveira and
• Marcos Vinicius da Silva

Beilstein J. Nanotechnol. 2024, 15, 1619–1626, doi:10.3762/bjnano.15.127

• enhance BBB penetration. Studies have shown that polymeric biomimetic nanoparticles carrying proteins can penetrate the brain parenchyma and release active agents, demonstrated by the increased accumulation of 3D6-Fab antibody fragments in the brains of mouse models, and reducing Aβ1-42 aggregation, which

Recent progress in cancer cell membrane-based nanoparticles for biomedical applications

• Qixiong Lin,
• Yueyou Peng,
• Yanyan Wen,
• Xiaoqiong Li,
• Donglian Du,
• Weibin Dai,
• Wei Tian and
• Yanfeng Meng

Beilstein J. Nanotechnol. 2023, 14, 262–279, doi:10.3762/bjnano.14.24

• environment (TME) because of immune evasion and cancer targeting abilities [15]. Moreover, biomimetic nanoparticles provide significant advantages regarding biocompatibility, low cytotoxicity, and structural support [16]. With the rapid development of biomimetic nanotechnology different types of derived

• adapted with permission from [14]. Copyright 2016, American Chemical Society. This content is not subject to CC BY 4.0. Characterization of membrane-encapsulated NPs. (A) Gel electrophoresis analysis showed that liver cancer biomimetic nanoparticles (a) basically retained and transferred the extracted

• cancer cell membrane protein components (b), which were similar to the cell lysate (c). (B) The box plot shows that the dimensional stability of cancer cell membrane biomimetic nanoparticles in water and PBS is significantly higher than that of bare nanoparticles. Adapted from [31]. (© 2019 Liu X et al